The Competitiveness Of The Pharmaceutical Industry In Malaysia: An Application Of Extended Porter’s Diamond Model
The Malaysian pharmaceutical manufacturing industry is facing several competitiveness issues. Among the issues are declining profitability, an increase in the number of competitors, poor export performance, limited production capacity, and a lack of innovation capabilities. Previous pharmaceutica...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2022
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/58470/1/CHONG%20HOOI%20YING%20-%20TESIS.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The Malaysian pharmaceutical manufacturing industry is facing several
competitiveness issues. Among the issues are declining profitability, an increase in the
number of competitors, poor export performance, limited production capacity, and a lack
of innovation capabilities. Previous pharmaceutical competitiveness literature
demonstrates that home country business environment factors play an important role in
determining the industry competitiveness in international trade. However, the relationship
between home country business environment factors and pharmaceutical firm
competitiveness in terms of profitability and market share remains largely unexplored.
Therefore, the purpose of this study is to investigate the influences of national business
environment factors on pharmaceutical firm competitiveness for a sample of 30
prescription medicines manufacturing firms operating in Malaysia from 2004 to 2018.
The theoretical foundation for this research is primarily derived from Porter's Diamond
Model. Static panel regression method is used to estimate the relationships between home
country business environment factors and the firm competitiveness of the Malaysian
pharmaceutical manufacturing industry. The findings suggest that country’s healthcare
expenditure per capita, capital investment efficincy, pharmaceutical exports, firm age,
and size are important in improving the firm competitiveness of Malaysia's
pharmaceutical manufacturing industry. |
|---|